2nd Oncology Partnering & Deal Making Conference
25 Feb 2013 - 26 Feb 2013 - Las Vegas, NV, USA
We welcome you to GTC's 2nd Oncology Partnering & Deal Making Conference, taking place on February 25-26, 2013 in Las Vegas, NV. This event is a partnering and business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations and learn about relevant issues in Oncology and partnerships that will affect the industry. This event also provides a unique venue for attendees to learn about Oncology business development trends, markets, and novel technologies that shape the industry. The top companies and experts in the Oncology field will come together to discuss the latest discoveries, technologies and partnership opportunities from their organization. Join your business development colleagues at this unique partnering forum!
2013 Preliminary Sessions:
Investments, Partnerships & Acquisitions: Trends & Recent Deals
Regulatory and Reimbursement Trends & UpdatesInnovative Partnering & Licensing Strategies
Trends in Oncology Drug Development
Novel Advances and Technologies in Oncology
This conference is part of our 2nd Novel Cancer Therapeutics Summit which consists of two other concurrent conferences shown below:
2nd Novel Cancer Therapeutics Summit:
Track: 2nd Oncology Partnering & Deal-making
Track: 4th Cancer Targets & Therapeutics
Track: 3rd Ubiquitin Research & Drug Discovery
Sign up for the Summit Pass to have access to all tracks of the summit!
Call for Papers!
To be considered for an oral presentation, please submit an abstract here by January 25, 2013. Selected presentations will be based on quality of abstract and availability. Presentation slots fill up fast so please submit your abstract ASAP.
Sponsorship and exhibiting opportunities are available in a range of levels, which can be tailored to fit your needs. Please contact 626-256-6405 x102 or email@example.com for more information.